A physician-led exploration of the biological systems that shape aging, performance, and long-term resilience — grounded in clinical practice and thoughtful analysis.
Explore the AMBAR trial and promising research on therapeutic plasma exchange for Alzheimer's disease. Learn about TPE at IFHO in Maryland.
APOE is the most common genetic risk factor for Alzheimer's and one of the most misunderstood. Dr. Bajnath explains what an APOE result can and cannot tell you, and when genetic testing actually changes clinical care.
BPC-157, TB-500, GHK-Cu, KPV and blends like Wolverine and GLOW — what the evidence supports, what it doesn't, and why physicians should stay involved.
An evidence-based physician guide to regenerative medicine: what it is, what it isn’t, stem cell types, FDA regulation, and real safety considerations.
Discover why longevity medicine outcomes remain inconsistent—and how true results only come from a strategy-first, diagnostic-led approach. We break down the risks of therapy stacking (hormones, peptides, IVs) without context, the crucial role of biological "terrain," and why the Institute for Human Optimization model avoids common clinical pitfalls to achieve genuine healthspan optimization.
Discover why redox balance—not just oxidative stress—sits at the center of healthy aging and mitochondrial resilience. This post explains how ROS signaling, antioxidant systems, and mitochondrial adaptation shape healthspan. Learn why non-targeted antioxidants miss the mark, and see how longevity medicine measures and supports true redox adaptability.
© Copyright The Institute for Human Optimization 2025.
All Rights Reserved.
